Rise in prevalence of chronic disease, increase in old age population, and improved life expectancy drive the growth of the global compounding pharmacies market.
PORTLAND, Ore., Aug. 5, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Compounding Pharmacies Market by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements, Others), by Route of Administration (Oral, Topical, Others), by Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global compounding pharmacies industry was estimated at $8.12 billion in 2021, and is anticipated to hit $14.84 billion by 2031, registering a CAGR of 6.2% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape.
Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12285
Drivers, restraints, and opportunities-
Rise in prevalence of chronic disease, increase in old age population, and improved life expectancy drive the growth of the global compounding pharmacies market. At the same time, growing drug failure rate and massive drug shortage across the globe have supplemented the growth yet more. On the other hand, increase in restrictions on manufacturing of complex formulations hinders the growth to some extent. However, huge growth potential in emerging economies has been highly beneficial for the market.
Covid-19 scenario-
- Amidst the global health crisis, the demand for compounded medication witnessed a steep incline in 2021, due to increased demand for quite a lot of medications for the treatment of Covid-19.
- Reduced manufacturing activities due to restrictions and shortage of commercially available drugs gave way to increased adoption of a compounded medication.
- Moreover, FDA gave out a temporary guidance policy to the federal facilities and state-licensed pharmacies, comprising hospital pharmacies and compounding pharmacies that are not listed with FDA as outsourcing facilities for compounding certain medication for hospitalized patients, owing to shortage of generic drugs.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/12285?reqfor=covid
The pain management segment to dominate by 2031-
By therapeutic area, the pain management segment contributed to nearly two-fifths of the global compounding pharmacies market share in 2021, and is expected to lead the trail by 2031. This is attributed to rise in number of geriatric populations, increase in number of surgical procedures, and surge in healthcare expenditure across the world. The others segment, however, is expected to exhibit the fastest CAGR of 7.3% from 2022 to 2031, due to rise in prevalence of neurological disorders and cancer cases.
The oral segment to rule the roost-
Based on route of administration, the oral segment generated more than two-fifths of the global compounding pharmacies market revenue in 2021, and is expected to lead the trail by 2031, due to huge availability of various medications that are meant to be orally administered. The others segment, on the other hand, would manifest the fastest CAGR of 6.7% from 2022 to 2031. Rise in product affordability, increase in geriatric population, and growing acceptance among the customers about compounding medications propel the segment growth.
The non-sterile compounding drugs segment to maintain the lion's share-
By sterility, the non-sterile compounding drugs segment garnered more than two-thirds of the global compounding pharmacies market share in 2021, and is expected to retain its dominance by 2031. The same segment is also expected to exhibit the fastest CAGR of 6.5% from 2022 to 2031. This is due to increase in prevalence of chronic disease such as diabetes, mounting demand for personalized medicines, and increase in the geriatric population across the world.
Purchase Inquire:
https://www.alliedmarketresearch.com/purchase-enquiry/12285
North America garnered the major share in 2021-
Based on region, North America held the major share in 2021, generating more than half of the global compounding pharmacies market. The well-established healthcare system, increase in number of geriatric patients, and supportive reimbursement policies across the province drive the market growth. Asia-Pacific, on the other hand, would garner the fastest CAGR of 7.3% by 2031. The growing medical tourism industry and rising public awareness regarding the benefits of compounding medications fuel the market growth.
Key players in the industry-
- Athenex Pharma Solutions
- B. Braun Melsungen AG
- Fresenius SE and Co. KGaA
- Advanced Pharmacy
- McGuff Companies, Inc.
- Nephron pharmaceuticals
- RX3 compounding pharmacy
- Valor Compounding Pharmacy
- ITC compounding pharmacy
- Dougherty's Pharmacy, Inc.
- Rx express compounding pharmacy
- Perrigo Company Plc (Fagron)
- New Compounding Pharma
- Institutional pharmacy solutions
- Olympia Compounding Pharmacy
- Panacea Biomatx Inc (Triangle Compounding Pharmacy)
- Pencol compounding pharmacy
The report analyzes these key players in the global compounding pharmacies market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):
Scaffold Technology Market by Product Type (Natural Scaffold and Synthetic Scaffold), by Type (Macro-porous Scaffolds, Micro-porous Scaffolds, Nano-porous Scaffolds, Solid Scaffolds), Application (Cancer Cell Research, Stem Cell Research, Drug Discovery, Regenerative Medicine, and Others), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027
Workplace Stress Management Market by Service (Stress Assessment, Yoga & Meditation, Resilience Training, Progress Tracking Metrics, and Others), Delivery Mode (Individual Counselors, Personal Fitness Trainers, Meditation Specialists, and Others), End User (Large Private Organizations, Mid-sized Private Organizations, Small Private Organizations, NGO, and Public Sector): Global Opportunity Analysis and Industry Forecast, 2020–2027
Traditional Wound Management Market by Product (Gauze, Bandage, Cotton, and Others), Application (Acute wound and Chronic Wound), and End User (Hospital & Clinics, Home Healthcare, Ambulatory Surgical center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028
Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028
Mother and Child Healthcare Market by Service (Pre-Natal Services, Birthing Services, Post-Natal Services, and Fertility Services), Maternal Age (Under 20, 21 to 30, 31 to 38, and 39 & Above), and Location (Hospitals, Nursing Homes & Clinics, In-Home Services and Online): Global Opportunity Analysis and Industry Forecast, 2021–2030
Gene Editing Market By Technology (Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas9 Gene Editing, Restriction Enzymes, Others), By Application (Gene editing, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug development, Others), By End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2031
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
SOURCE Allied Market Research
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO36695&Transmission_Id=202208050330PR_NEWS_USPR_____IO36695&DateId=20220805)
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
![icon3](/content/dam/newsfeatured/icon3.png)
Newsrooms &
Influencers
![icon1](/content/dam/newsfeatured/icon1.png)
Digital Media
Outlets
![icon2](/content/dam/newsfeatured/icon2.png)
Journalists
Opted In
Share this article